Delivery Order SPE2DR25D2218-SPE2DR26FX3M8
Award Date 11/6/25
Potential Completion Date 11/7/25
Potential Value $1.9K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $1,092.15 delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Savella 50 mg tablets (60-count packages). This firm fixed-price, non-set-aside contract will be fulfilled from the vendor's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of August 19, 2025. The delivery order represents a child contract under AmerisourceBergen's broader pharmaceutical supply agreement with the DLA....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 22, 2025, for the supply of Savella 50 mg tablets (60-count units) under a firm fixed-price contract. The order, valued at $1,412.55, is set to be completed by August 25, 2025, and will be fulfilled from the contractor's Conshohocken, Pennsylvania facility. This delivery order represents a non-set-aside, competitively awarded procurement and serves as a child order under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a $1,580.37 delivery order to AmerisourceBergen Drug Corp on September 5, 2025, for the supply of Savella (milnacipran) 50 mg tablets in a 60-count quantity. This firm fixed-price delivery order, with an ultimate completion date of September 8, 2025, represents a competitively awarded, non-set-aside contract for pharmaceutical procurement. The medication will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Savella 50 mg tablets (60-count units) on August 22, 2025, with a ceiling value of $8,031.09 and an ultimate completion date of August 25, 2025. This non-set-aside, firm fixed-price contract is classified as a delivery order, indicating it falls under a larger indefinite delivery vehicle. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,152.26 to AmerisourceBergen Drug Corp for the supply of Savella 25 mg tablets (60-count) on October 29, 2025, with an ultimate completion date of October 30, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999.999 billion through December...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The $1,309.08 firm fixed price delivery order is for the supply of Savella 50 mg tablets. The contract has an ultimate completion date of May 3, 2024. Amerisourcebergen Drug Corp is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, particularly the Department of Defense (DoD) and Department of Veterans Affairs (VA)...
- The Defense Logistics Agency awarded a delivery order valued at $3,237.86 to AmerisourceBergen Drug Corp for Savella 100 mg tablets (60-count units) on August 13, 2025, with completion targeted for August 14, 2025. This firm fixed-price delivery order represents a non-competitive set-aside contract and will be fulfilled at the contractor's corporate office location in Conshohocken, Pennsylvania. Savella (milnacipran) is a serotonin-norepinephrine reuptake inhibitor indicated for fibromyalgia...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation. The $6,594.81 award is for the supply of Savella 50 mg tablets, a prescription medication, to support military treatment programs and facilities. AmerisourceBergen Drug Corp holds an indefinite delivery contract (IDC) with DLA, valued at up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for the...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of 60 tablets of the medication Savella 25 mg. The contract, valued at $1,149.00, has a completion date of March 29, 2024. Amerisourcebergen Drug Corp is the prime contractor and has an existing indefinite delivery contract (IDC) with DLA, valued at up to $999,999,999.00, which serves as the primary vehicle for...
- The Defense Logistics Agency awarded a $7,980.01 delivery order to AmerisourceBergen Drug Corp for 60 tablets of Savella 50 mg, a medication used to treat fibromyalgia. Issued on June 18, 2025, with an ultimate completion date of June 20, 2025, this firm fixed-price contract represents a non-set-aside competitive award. The product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters and primary distribution operations. This delivery order...